B. Riley Wealth Advisors Inc. Reduces Stock Position in Sanofi (NASDAQ:SNY)

B. Riley Wealth Advisors Inc. decreased its stake in shares of Sanofi (NASDAQ:SNY) by 20.1% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 16,722 shares of the company’s stock after selling 4,203 shares during the quarter. B. Riley Wealth Advisors Inc.’s holdings in Sanofi were worth $811,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in SNY. Vestal Point Capital LP acquired a new stake in shares of Sanofi in the 4th quarter worth $14,919,000. Dynamic Advisor Solutions LLC grew its holdings in shares of Sanofi by 39.2% in the first quarter. Dynamic Advisor Solutions LLC now owns 57,204 shares of the company’s stock valued at $2,780,000 after purchasing an additional 16,117 shares during the period. Manning & Napier Advisors LLC purchased a new position in Sanofi during the second quarter worth about $13,725,000. Mount Yale Investment Advisors LLC boosted its holdings in Sanofi by 44.3% in the 1st quarter. Mount Yale Investment Advisors LLC now owns 41,707 shares of the company’s stock valued at $2,027,000 after purchasing an additional 12,806 shares during the last quarter. Finally, Jennison Associates LLC boosted its holdings in Sanofi by 18.9% in the 1st quarter. Jennison Associates LLC now owns 189,622 shares of the company’s stock valued at $9,216,000 after purchasing an additional 30,115 shares during the last quarter. Institutional investors and hedge funds own 10.04% of the company’s stock.

Sanofi Stock Down 0.1 %

Sanofi stock opened at $55.47 on Friday. The company has a market capitalization of $140.49 billion, a PE ratio of 27.87, a price-to-earnings-growth ratio of 1.62 and a beta of 0.60. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.65 and a current ratio of 1.00. Sanofi has a fifty-two week low of $42.63 and a fifty-two week high of $58.97. The firm has a 50 day moving average price of $55.46 and a 200 day moving average price of $51.04.

Sanofi (NASDAQ:SNY) last issued its quarterly earnings data on Thursday, July 25th. The company reported $0.93 earnings per share for the quarter, beating analysts’ consensus estimates of $0.88 by $0.05. Sanofi had a return on equity of 26.29% and a net margin of 9.60%. The business had revenue of $10.75 billion during the quarter, compared to analysts’ expectations of $16.86 billion. During the same period in the previous year, the firm posted $0.95 earnings per share. The company’s revenue was up 7.8% on a year-over-year basis. Research analysts expect that Sanofi will post 4.26 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have recently commented on SNY shares. Argus lifted their price target on shares of Sanofi from $55.00 to $60.00 and gave the company a “buy” rating in a research report on Friday, July 26th. Citigroup raised Sanofi to a “strong-buy” rating in a research note on Tuesday, September 17th. Finally, StockNews.com raised Sanofi from a “buy” rating to a “strong-buy” rating in a research report on Wednesday. Three equities research analysts have rated the stock with a hold rating, one has issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $57.50.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.